PeerVoice Oncology & Haematology Audio

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

http://www.peervoice.com

Eine durchschnittliche Folge dieses Podcasts dauert 19m. Bisher sind 263 Folge(n) erschienen. Dies ist ein wöchentlich erscheinender Podcast.

Gesamtlänge aller Episoden: 4 days 13 hours 29 minutes

subscribe
share






Insights and Strategies for Individualising Therapy for ALK-Positive NSCLC: Updates From Recent Medical Congresses


Go online to www.peervoice.com/h/pvs62 to view the entire programme with slides.


share








 2014-08-08  10m
 
 

CD30+ T-Cell Lymphomas: Improving the Blueprint of Care


CD30+ T-Cell Lymphomas: Improving the Blueprint of Care


share








 2014-08-05  1h3m
 
 

Second-Line Therapies for EGFR Wild-Type NSCLC: What Is the Best Treatment? That Is the Question!


Go online to www.peervoice.com/h/pve44 to view the entire programme with slides.


share








 2014-08-01  21m
 
 

The Evolving Landscape in Targeted Therapy for Metastatic Colorectal Cancer: Impact of Recent Data on Practice and Patients


Go online to www.peervoice.com/h/pvs59 to view the entire programme with slides.


share








 2014-07-21  18m
 
 

Optimal First-Line Treatment of EGFR-Mutation–Positive Non–Small-Cell Lung Cancer: What’s Changed for 2014?


Go online to www.peervoice.com/h/pve46 to view the entire programme with slides.


share








 2014-07-10  30m
 
 

A Patient-Centered Approach to BRAFV600 Mutated Metastatic Melanoma: Expert Insights on Managing Patients With Confidence


Go online to www.peervoice.com/h/pvr138 to view the entire programme with slides.


share








 2014-05-30  18m
 
 

Using Targeted Therapies to Overcome Radioactive Iodine Resistance in Advanced Differentiated Thyroid Cancer


Go online to www.peervoice.com/h/pvr147 to view the entire programme with slides.


share








 2014-05-22  14m
 
 

Conversations in Cardiology: Improving Recognition and Management of Hypertrophic Cardiomyopathy


Conversations in Cardiology: Improving Recognition and Management of Hypertrophic Cardiomyopathy


share








 1970-01-01  27m
 
 

PARPs in Practice in mCRPC: A Look at the Latest Data


PARPs in Practice in mCRPC: A Look at the Latest Data


share








 1970-01-01  17m
 
 

Quality of Life in Patients With Advanced Renal Cell Carcinoma: Are We Measuring What Matters?


Quality of Life in Patients With Advanced Renal Cell Carcinoma: Are We Measuring What Matters?


share








 1970-01-01  23m